Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors
Open Access
- 1 July 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 15 (7) , 997-1006
- https://doi.org/10.1002/ibd.20880
Abstract
Background. Patients with ulcerative colitis are at increased risk for developing colorectal cancer. We have shown that Toll-like receptor-4 (TLR4) is overexpreKeywords
This publication has 50 references indexed in Scilit:
- Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitisJournal of Clinical Investigation, 2008
- Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal TumorsGastroenterology, 2007
- Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort StudyGastroenterology, 2007
- Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventionsActa Pharmacologica Sinica, 2007
- Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injuryJournal of Clinical Investigation, 2007
- Cox-2 Is Regulated by Toll-Like Receptor-4 (TLR4) Signaling: Role in Proliferation and Apoptosis in the IntestineGastroenterology, 2006
- NF‐κB and cancer: Mechanisms and targetsMolecular Carcinogenesis, 2006
- Toll-Like Receptor 4 Contributes to Colitis Development but Not to Host Defense during Citrobacter rodentium Infection in MiceInfection and Immunity, 2006
- NF-κB functions as a tumour promoter in inflammation-associated cancerNature, 2004
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004